Medpace Holdings Inc (MEDP) — Capital Reinvestment Ratio

Latest as of December 2025: 0.02x

Medpace Holdings Inc (MEDP) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow ($192.65 Million) in capital expenditures ($4.54 Million). See MEDP net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.02x
Capex / Operating Cash Flow

Operating Cash Flow

$192.65 Million
USD

Capital Expenditures

$4.54 Million
USD

Data as of

Dec 2025
Most recent filing

Medpace Holdings Inc Capital Reinvestment Ratio (2013–2025)

This chart tracks Medpace Holdings Inc's Capital Reinvestment Ratio across 13 annual periods. Check how aggressively does Medpace Holdings Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Medpace Holdings Inc (2013–2025)

Year-by-year Capital Reinvestment Ratio for Medpace Holdings Inc from 2013 to 2025. For live market cap and broader valuation context, see MEDP stock market capitalisation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.04x $713.22 Million $31.36 Million ▼ -26.8%
2024 0.06x $608.82 Million $36.55 Million ▼ -29.0%
2023 0.08x $433.37 Million $36.65 Million ▼ -11.0%
2022 0.10x $388.05 Million $36.88 Million ▼ -11.5%
2021 0.11x $263.33 Million $28.27 Million ▼ -11.4%
2020 0.12x $258.68 Million $31.34 Million ▲ +36.5%
2019 0.09x $201.87 Million $17.91 Million ▼ -13.3%
2018 0.10x $156.58 Million $16.02 Million ▼ -18.9%
2017 0.13x $97.39 Million $12.29 Million ▼ -14.5%
2016 0.15x $91.73 Million $13.54 Million ▲ +96.0%
2015 0.08x $85.87 Million $6.46 Million ▲ +6.5%
2014 0.07x $75.20 Million $5.32 Million ▲ +52.1%
2013 0.05x $98.14 Million $4.56 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow